BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28811133)

  • 21. Design, synthesis, and identification of a novel napthalamide-isoselenocyanate compound NISC-6 as a dual Topoisomerase-IIα and Akt pathway inhibitor, and evaluation of its anti-melanoma activity.
    Karelia DN; Sk UH; Singh P; Gowda ASP; Pandey MK; Ramisetti SR; Amin S; Sharma AK
    Eur J Med Chem; 2017 Jul; 135():282-295. PubMed ID: 28458134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRM1 inhibitory and antiproliferative activities of novel 4'-alkyl substituted klavuzon derivatives.
    Kanbur T; Kara M; Kutluer M; Şen A; Delman M; Alkan A; Otaş HO; Akçok İ; Çağır A
    Bioorg Med Chem; 2017 Aug; 25(16):4444-4451. PubMed ID: 28689976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Cytotoxic and Heparanase Inhibition Studies of 5-oxo-1-arylpyrrolidine-3- carboxamides of Hydrazides and 4-amino-5-aryl-4H-1,2,4-triazole-3-thiol.
    Hari S; Swaroop TR; Preetham HD; Mohan CD; Muddegowda U; Basappa S; Vlodavsky I; Sethi G; Rangappa KS
    Curr Org Synth; 2020; 17(3):243-250. PubMed ID: 32096746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities.
    Sangthong S; Krusong K; Ngamrojanavanich N; Vilaivan T; Puthong S; Chandchawan S; Muangsin N
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4813-8. PubMed ID: 21741833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.
    Wang S; Yang H; Su M; Lian F; Cong Z; Wei R; Zhou Y; Li X; Zheng X; Li C; Fu X; Han X; Shi Q; Li C; Zhang N; Geng M; Liu H; Li J; Huang X; Wang J
    Eur J Med Chem; 2021 Oct; 222():113592. PubMed ID: 34147909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
    El-Gamal MI; Ullah S; Zaraei SO; Jalil S; Zaib S; Zaher DM; Omar HA; Anbar HS; Pelletier J; Sévigny J; Iqbal J
    Eur J Med Chem; 2019 Nov; 181():111560. PubMed ID: 31382118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties.
    Dulla B; Kirla KT; Rathore V; Deora GS; Kavela S; Maddika S; Chatti K; Reiser O; Iqbal J; Pal M
    Org Biomol Chem; 2013 May; 11(19):3103-7. PubMed ID: 23575971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
    Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
    Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
    Schoenfeld AK; Vierfuß S; Lühn S; Alban S
    J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and in vitro evaluation of β-glucuronidase-sensitive prodrug of 5-aminolevulinic acid for photodiagnosis of breast cancer cells.
    Herceg V; Adriouach S; Janikowska K; Allémann E; Lange N; Babič A
    Bioorg Chem; 2018 Aug; 78():372-380. PubMed ID: 29627657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes.
    Bollini M; Casal JJ; Bruno AM
    Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Anti-Proliferative Activity of Sulfanyltriazolylnaphthalenols and Sulfanyltriazolylnaphthalene-1,4-diones.
    Chaaban I; El Khawass el SM; Abd El Razik HA; El Salamouni NS; Redondo-Horcajo M; Barasoain I; Díaz JF; Yli-Kauhaluoma J; Moreira VM
    Arch Pharm (Weinheim); 2016 Sep; 349(9):749-61. PubMed ID: 27404773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.
    Pan W; Miao HQ; Xu YJ; Navarro EC; Tonra JR; Corcoran E; Lahiji A; Kussie P; Kiselyov AS; Wong WC; Liu H
    Bioorg Med Chem Lett; 2006 Jan; 16(2):409-12. PubMed ID: 16246560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
    Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
    Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
    Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
    [No Abstract]   [Full Text] [Related]  

  • 36. Involvement of disulfide bond formation in the activation of heparanase.
    Simizu S; Suzuki T; Muroi M; Lai NS; Takagi S; Dohmae N; Osada H
    Cancer Res; 2007 Aug; 67(16):7841-9. PubMed ID: 17699790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
    Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
    Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models.
    Cassinelli G; Lanzi C; Tortoreto M; Cominetti D; Petrangolini G; Favini E; Zaffaroni N; Pisano C; Penco S; Vlodavsky I; Zunino F
    Biochem Pharmacol; 2013 May; 85(10):1424-32. PubMed ID: 23466421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid synthesis of new DNMT inhibitors derivatives of procainamide.
    Halby L; Champion C; Sénamaud-Beaufort C; Ajjan S; Drujon T; Rajavelu A; Ceccaldi A; Jurkowska R; Lequin O; Nelson WG; Guy A; Jeltsch A; Guianvarc'h D; Ferroud C; Arimondo PB
    Chembiochem; 2012 Jan; 13(1):157-65. PubMed ID: 22170584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives.
    Chen H; Wang CL; Sun T; Zhou Z; Niu JX; Tian XM; Yuan M
    Bioorg Med Chem Lett; 2018 May; 28(9):1534-1539. PubMed ID: 29615343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.